Stay updated on KN046 and Ningatinib in Advanced HCC Clinical Trial
Sign up to get notified when there's something new on the KN046 and Ningatinib in Advanced HCC Clinical Trial page.

Latest updates to the KN046 and Ningatinib in Advanced HCC Clinical Trial page
- Check5 days agoChange DetectedRevision v3.4.3 was added to the record history and the previous revision v3.4.2 was removed.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded a new revision entry (v3.4.2) to the record history and removed the funding-notice banner previously shown on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check41 days agoChange DetectedAdded a site-wide notice about government funding and operating status, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check48 days agoChange DetectedUI enhancements include showing the glossary, green and red highlights for additions and deletions, and a new revision label (v3.4.0), with minor wording changes such as 'No FEAR Act Data'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check62 days agoChange DetectedA new revision labeled v3.3.4 was added to the record history, and the prior revision v3.3.3 was removed from the list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedA new revision label 'Revision: v3.3.3' was added, and the HHS Vulnerability Disclosure footer link along with 'Revision: v3.3.2' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to KN046 and Ningatinib in Advanced HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KN046 and Ningatinib in Advanced HCC Clinical Trial page.